Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
crispr
6
×
gene editing
6
×
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
editas medicine
ipo
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
biogen
boston
car-t
celgene
clinical study
clinical trials
commissioner
cynthia collins
deals
democrats
What
gene
bio
crispr
editas
editing
medicine
roundup
ceo
experimental
investors
katrine
million
moves
therapy
abbvie
allergan
alliance
allogene
becker
big
billions
biotech
blessing
bosley
bosley's
bosley’s
breathing
bridge
bucks
cancer
cas
check
clinical
close
colossal
companies
company
create
crime
crispr’s
Language
unset
Current search:
crispr
×
biotech
×
" gene editing "
×
@techcrunch.com
2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
